115 related articles for article (PubMed ID: 38081078)
1. Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle.
Da M; Li S; Yang R; Jia Z; Ma Y; Qi F; Zhao J; Shen G; Chen D
Nanotechnology; 2023 Dec; 35(11):. PubMed ID: 38081078
[TBL] [Abstract][Full Text] [Related]
2. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
[TBL] [Abstract][Full Text] [Related]
3. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.
Saxena V; Hussain MD
Int J Nanomedicine; 2012; 7():713-21. PubMed ID: 22359450
[TBL] [Abstract][Full Text] [Related]
4. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
[TBL] [Abstract][Full Text] [Related]
5. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance.
Wang S; Yang Y; Wang Y; Chen M
Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer.
Haggag YA; Yasser M; Tambuwala MM; El Tokhy SS; Isreb M; Donia AA
Int J Pharm; 2021 May; 600():120532. PubMed ID: 33781877
[TBL] [Abstract][Full Text] [Related]
7. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of in vitro and in vivo antitumor effects of gambogic acid-loaded layer-by-layer self-assembled micelles.
Ke Z; Yang L; Wu H; Li Z; Jia X; Zhang Z
Int J Pharm; 2018 Jul; 545(1-2):306-317. PubMed ID: 29654896
[TBL] [Abstract][Full Text] [Related]
9. Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles.
Chen R; Ni S; Chen W; Liu M; Feng J; Hu K
Int J Nanomedicine; 2021; 16():5265-5279. PubMed ID: 34376979
[TBL] [Abstract][Full Text] [Related]
10. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion.
Yu F; He C; Waddad AY; Munyendo WL; Lv H; Zhou J; Zhang Q
Drug Dev Ind Pharm; 2014 Jun; 40(6):774-82. PubMed ID: 23679668
[TBL] [Abstract][Full Text] [Related]
11. Lithocholic acid conjugated mPEG-b-PCL micelles for pH responsive delivery to breast cancer cells.
Isik G; Kiziltay A; Hasirci N; Tezcaner A
Int J Pharm; 2022 Jun; 621():121779. PubMed ID: 35500691
[TBL] [Abstract][Full Text] [Related]
12. Gambogic Acid-Loaded Polymeric Micelles for Improved Therapeutic Effect in Breast Cancer.
Wang Y; Liang X; Tong R; Yang J; Yang Y; Zhong J; Wu Q; Gong C; Yu J; Cai L
J Biomed Nanotechnol; 2018 Oct; 14(10):1695-1704. PubMed ID: 30041717
[TBL] [Abstract][Full Text] [Related]
13. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.
Doddapaneni R; Patel K; Owaid IH; Singh M
Drug Deliv; 2016 May; 23(4):1232-41. PubMed ID: 26701717
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of gambogic acid-loaded mixed micelles system for enhanced oral bioavailability.
Ke Z; Shi J; Cheng Z; Cheng X; Wang H; Wang M; Wu J; Sun Y; Li C
Pharm Dev Technol; 2022 Jul; 27(6):695-701. PubMed ID: 35899462
[TBL] [Abstract][Full Text] [Related]
17. Magnetically Guided Self-Assembled Protein Micelles for Enhanced Delivery of Dasatinib to Human Triple-Negative Breast Cancer Cells.
Sabra SA; Sheweita SA; Haroun M; Ragab D; Eldemellawy MA; Xia Y; Goodale D; Allan AL; Elzoghby AO; Rohani S
J Pharm Sci; 2019 May; 108(5):1713-1725. PubMed ID: 30528944
[TBL] [Abstract][Full Text] [Related]
18. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
[No Abstract] [Full Text] [Related]
19. Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery.
Zhang CY; Yang YQ; Huang TX; Zhao B; Guo XD; Wang JF; Zhang LJ
Biomaterials; 2012 Sep; 33(26):6273-83. PubMed ID: 22695069
[TBL] [Abstract][Full Text] [Related]
20. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
